AKOYA BIOSCIENCES INC (AKYA)       11.01  +0.13 (+1.19%)

11.01  +0.13 (+1.19%)

US00974H1041 - Common Stock - After market: 11.01 0 (0%)

News Image
20 days ago - Seeking Alpha

Akoya guides Q4 and FY revenue above consensus

Akoya Biosciences (AKYA) expects Q4 revenue to be between $20.7M and $21.2M, as compared to $16.2M for the corresponding quarter of last year vs consensus of $20.05M.For the FY22,...

News Image
21 days ago - Akoya Biosciences, Inc.

Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022

MARLBOROUGH, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
a month ago - Akoya Biosciences, Inc.

Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference

MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
a month ago - Akoya Biosciences, Inc.

Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day

New products and partnerships further accelerate and simplify identification of actionable spatial signatures, creating unprecedented opportunities to...

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance

Q3 2022 revenue $18.9 million, 40% y/y growthRaising FY 2022 revenue guidance range to $73-75 million MARLBOROUGH, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE)...

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya to Participate at Three Upcoming Investor Conferences

MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
4 months ago - Akoya Biosciences, Inc.

Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022

MARLBOROUGH, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
5 months ago - Akoya Biosciences, Inc.

Akoya to Participate at Four Upcoming Investor Conferences

MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
6 months ago - Akoya Biosciences, Inc.

Akoya to Participate at Two Upcoming Investor Conferences

MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
7 months ago - Akoya Biosciences, Inc.

Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
7 months ago - Akoya Biosciences, Inc.

Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to...

News Image
8 months ago - Akoya Biosciences, Inc.

Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting

PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capabilities on a single platform...